127 related articles for article (PubMed ID: 2835863)
21. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
[TBL] [Abstract][Full Text] [Related]
22. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.
Kirnbauer R; Taub J; Greenstone H; Roden R; Dürst M; Gissmann L; Lowy DR; Schiller JT
J Virol; 1993 Dec; 67(12):6929-36. PubMed ID: 8230414
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products.
Köchel HG; Sievert K; Monazahian M; Mittelstädt-Deterding A; Teichmann A; Thomssen R
Virology; 1991 Jun; 182(2):644-54. PubMed ID: 1850922
[TBL] [Abstract][Full Text] [Related]
24. Current concepts of human papillomavirus infections in the genital tract and their relationship to intraepithelial neoplasia and squamous cell carcinoma.
Syrjänen KJ
Obstet Gynecol Surv; 1984 May; 39(5):252-65. PubMed ID: 6326011
[No Abstract] [Full Text] [Related]
25. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children.
Cason J; Kambo PK; Best JM; McCance DJ
Int J Cancer; 1992 Feb; 50(3):349-55. PubMed ID: 1310487
[TBL] [Abstract][Full Text] [Related]
26. Coexpression of the human papillomavirus type 16 E4 and L1 open reading frames in early cervical neoplasia.
Crum CP; Barber S; Symbula M; Snyder K; Saleh AM; Roche JK
Virology; 1990 Sep; 178(1):238-46. PubMed ID: 2167552
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus vaccines.
Breitburd F; Coursaget P
Semin Cancer Biol; 1999 Dec; 9(6):431-44. PubMed ID: 10712890
[TBL] [Abstract][Full Text] [Related]
28. Expression of human papillomavirus type 6 E1, E2, L1 and L2 open reading frames in Escherichia coli.
Thompson GH; Roman A
Gene; 1987; 56(2-3):289-95. PubMed ID: 2445631
[TBL] [Abstract][Full Text] [Related]
29. Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles.
Zhou J; Sun XY; Davies H; Crawford L; Park D; Frazer IH
Virology; 1992 Aug; 189(2):592-9. PubMed ID: 1379392
[TBL] [Abstract][Full Text] [Related]
30. Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies.
Jin XW; Cowsert LM; Pilacinski WP; Jenson AB
J Gen Virol; 1989 May; 70 ( Pt 5)():1133-40. PubMed ID: 2471804
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of antibodies to human papillomavirus type 8 in human sera.
Steger G; Olszewsky M; Stockfleth E; Pfister H
J Virol; 1990 Sep; 64(9):4399-406. PubMed ID: 2166821
[TBL] [Abstract][Full Text] [Related]
32. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical demonstration of papillomavirus infection in condylomatous and preneoplastic lesions of the lower female genital tract.
Andrade LA; Oyakawa N; Vassallo J
Pathologica; 1991; 83(1085):301-6. PubMed ID: 1656376
[TBL] [Abstract][Full Text] [Related]
34. Presence of human papilloma virus types 16 and 18 in genital warts and cervical neoplasias.
Battista C; Hillova J; Hill M; Reynès M; Mathé G
Med Oncol Tumor Pharmacother; 1988; 5(1):1-9. PubMed ID: 2835559
[TBL] [Abstract][Full Text] [Related]
35. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
36. Relative enhancer activity and transforming potential of authentic human papillomavirus type 6 genomes from benign and malignant lesions.
Farr A; Wang H; Kasher MS; Roman A
J Gen Virol; 1991 Mar; 72 ( Pt 3)():519-26. PubMed ID: 1848589
[TBL] [Abstract][Full Text] [Related]
37. Binding by immunoglobulin to the HPV-16-derived proteins L1 and E4 in cervical secretions of women with HPV-related cervical disease.
Snyder KA; Barber SR; Symbula M; Taylor PT; Crum CP; Roche JK
Cancer Res; 1991 Aug; 51(16):4423-9. PubMed ID: 1651158
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
[TBL] [Abstract][Full Text] [Related]
39. Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33.
Volpers C; Sapp M; Komly CA; Richalet-Secordel P; Streeck RE
J Virol; 1993 Apr; 67(4):1927-35. PubMed ID: 8383218
[TBL] [Abstract][Full Text] [Related]
40. Detection of infection by human papillomavirus in genital condylomata. A comparison study using immunocytochemistry and in situ nucleic acid hybridization.
Wilbur DC; Reichman RC; Stoler MH
Am J Clin Pathol; 1988 Apr; 89(4):505-10. PubMed ID: 2833093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
